MY [CHINA MING YANG WIND POWER] 6-K: (Original Filing)

[MING YANG FORMS STRATEGIC PARTNERSHIP WITH RELIANCE STYLE="font-family:Times New Roman" SIZE="2"> DEVELOPMENT OF UP TO 2,500 MW CLEAN ENERGY PROJECTS IN INDIA AND EXPANSION INTO SOUTHIA REGION Zhongshan, China, July2, 2012 STYLE="font-family:Times New Roman" SIZE="2">Indition, thempany has signed a Memorandum of Understanding (MOU, together with the definitivereementsove mentioned,reements) with Reliance Power Limited (Reliance Power), the]

By | 2016-02-05T00:45:40+00:00 July 3rd, 2012|Categories: Chinese Stocks, MY, SEC Original|Tags: , , , , , |0 Comments

SHI [SINOPEC SHANGHAI PETROCHEMICAL CO] 6-K: (Original Filing)

[Form 6-K TABLE OF CONTENTS 3 Resolutions Passed at the 2011 Annual General Meeting 4 List of Directors and their Role and Function 10 Amended and Restated Articles of Association 11 - 2 - SINOPEC SHANGHAI PETROCHEMICAL COMPANY LIMITED Wang Zhiqing President - 3 - (A joint stock limited company incorporated in the People’s Republic of China) (Stock Code: 00338)]

XRS [TAL Education] 6-K: (Original Filing)

[TAL Education Announces the Filing of Its Annual Report on Form20-F TALs annual report on Form20-F, whichntains its auditednsolidated financial statements, is available on the SECs website at www.sec.gov, and on TALs investor relations website at en.xueersi.org/investor. TAL will provide a hardpy of its annual report, free of charge, to its shareholders andS holders upon]

By | 2016-02-04T08:28:02+00:00 July 3rd, 2012|Categories: Chinese Stocks, SEC Original, XRS|Tags: , , , , , |0 Comments

CCIH [ChinaCache International] 6-K: (Original Filing)

[ChinaCache Announces Results of 2012 Annual General Meeting Beijing, July 2, 2012 - ChinaCache International Holdings Ltd. (NASDAQ: CCIH), the leading total solutions provider of content delivery network services in China, today announced that its 2012 annual general meeting of shareholders was held in Hong Kong on July 2, 2012. About ChinaCache International Holdings Ltd. ChinaCache International Holdings Ltd. (NASDAQ:] [ChinaCache International Holdings Ltd. 6/F, Block A, Galaxy Plaza 10 Jiuxianqiao Road Middle, Chaoyang District Beijing 100015 The People’s Republic of China +86 10 6437 3399 Form 20-F x Form 40-F o o o ChinaCache International Holdings Ltd.]

CBPO [China Biologic Products] DEFR14A: (Original Filing)

[SCHEDULE 14A (Amendment No. 1) Check the appropriate box: [ ] Preliminary Proxy Statement CHINA BIOLOGIC PRODUCTS, INC. __________________________________________________________ Payment of Filing Fee (Check the appropriate box): [X] No fee required. [ ] Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11. (1) Title of each class of securities to which transaction applies: (2) Aggregate number of]

CJJD [CHINA JO-JO DRUGSTORES] 10-K: (Original Filing)

[FORM 10-K þ For the fiscal year ended March 31, 2012 or o For the transition period from ____________________________________ to ________________________________________ 001-34711 CHINA JO-JO DRUGSTORES, INC . (Exact name of issuer as specified in its charter) Nevada 98-0557852 (State or other jurisdiction of incorporation or organization) (I.R.S. employer identification number) Room 507-513, 5th Floor A Building, Meidu Plaza Gongshu District] [List of Subsidiaries 1. Renovation Investment (Hong Kong) Co., Ltd. (“Renovation”) is a Hong Kong company and is wholly-owned by the Company. 2. Hangzhou Jiutong Medical Technology Co., Ltd. is a Chinese company and is wholly-owned by Renovation. 3. Zhejiang Shouantang Pharmaceutical Technology Co., Ltd. (“Shouantang Technology”) is a Chinese company and is wholly-owned by Renovation. 4. Zhejiang Jiuxin Investment] [CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM We hereby consent to the incorporation by reference in the Registration Statements on Form S-8 (File No. 333-171849) of China Jo-Jo Drugstores, Inc. and subsidiaries of our reports dated July 2, 2012 relating to the consolidated financial statements, which appear in this Form 10-K. New York, New York July 2, 2012 EX-23.1 3] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Lei Liu, certify that: 1. I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ming Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of China Jo-Jo Drugstores, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Lei Liu Chief Executive Officer July 2, 2012 EX-32.1 6 f10kex32i_chinajojo.htm CERTIFICATION] [18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 Ming Zhao Chief Financial Officer July 2, 2012 EX-32.2 7 f10kex32ii_chinajojo.htm CERTIFICATION]

CJJD [CHINA JO-JO DRUGSTORES] 8-K: (Original Filing)

[China Jo-Jo Drugstores, Inc. Reports Fiscal Year 2012 Earnings Results and schedules conference call for July 3, 2012 Fiscal Year 2012 Highlights: --Revenues reached record $94.4 million --Gross profit rose 30% to $27.6 million, gross margin 29% --Sales from the cultivation of Traditional Chinese Medicines were $4.2 million, from online drug sales was $1.1 million --Net income $8.1 million --Diluted]

HIHO [HIGHWAY] 6-K: (Original Filing)

[NEWS RELEASE CONTACT: Gary S. Maier Maier & Company, Inc. (310) 442-9852 HIGHWAY HOLDINGS REPORTS FISCAL FOURTH QUARTER/ YEAR-END RESULTS 2012 HONG KONG —June 29, 2012 — Nasdaq: HIHO Net income for the fiscal fourth quarter was $92,000, or $0.02 per diluted share, compared with $789,000, or $0.21 per diluted share, a year earlier. Net sales for the same period]

Skip to toolbar